Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Affimed N.V. - Common Stock
(NQ:
AFMD
)
0.1815
UNCHANGED
Last Price
Updated: 4:00 PM EDT, May 19, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Affimed N.V. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
Affimed Touts Encouraging Patient Responses For Its NK Cell Therapy In Lymphoma Settings
April 11, 2022
Affimed N.V. (NASDAQ: AFMD)
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
April 11, 2022
Rise and shine, investor! It's time to start off another week of trading with the biggest pre-market stock movers for Monday!
Via
InvestorPlace
Recap: Affimed Q4 Earnings
March 31, 2022
Affimed (NASDAQ:AFMD) reported its Q4 earnings results on Thursday, March 31, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
The Daily Biotech Pulse: Amylyx Announces Negative Adcom Vote, Clovis Jumps On Ovarian Cancer Data, Masimo Warns Of Q1 Shortfall
March 31, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Recap: Affimed Q3 Earnings
November 10, 2021
Affimed (NASDAQ:AFMD) reported its Q3 earnings results on Wednesday, November 10, 2021 at 08:00 AM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
Affimed Earnings Preview
June 30, 2021
Affimed (NASDAQ:AFMD) announces its next round of earnings this Thursday, July 01. Here is Benzinga's look at Affimed's Q1 earnings report. Net Income, Earnings, And Earnings Per...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2022
March 31, 2022
Upgrades
Via
Benzinga
Earnings Outlook For Affimed
March 30, 2022
Affimed (NASDAQ:AFMD) is set to give its latest quarterly earnings report on Thursday, 2022-03-31. Here's what investors need to know before the announcement. Analysts estimate that Affimed will report...
Via
Benzinga
The Daily Biotech Pulse: Roche's Lung Cancer Combo Therapy Flunks Late-Stage Study, Adagio Spikes On Positive COVID Antibody Data, Amylyx Awaits Adcom Verdict
March 30, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
Earnings Scheduled For March 31, 2022
March 31, 2022
Companies Reporting Before The Bell • Trevena (NASDAQ:TRVN) is likely to report earnings for its fourth quarter.
Via
Benzinga
20 Stocks Moving in Thursday's Pre-Market Session
March 24, 2022
Gainers Mercurity Fintech Holding Inc. (NYSE: MFH) rose 91% to $4.03 in pre-market trading. Energy Services of America Corporation (NASDAQ: ESOA) shares rose 40% to $4.62 in pre-...
Via
Benzinga
The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More
March 27, 2022
Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money out of defensives and into risky bets.
Via
Benzinga
3 Best Biopharma Stocks to Buy During This Industrywide Fire Sale
November 28, 2021
Affimed, Amgen, and Bristol Myers Squibb are too cheap to ignore right now.
Via
The Motley Fool
Affimed's Lymphoma Candidate Shows 100% Objective Response Rate At Highest Dose
November 22, 2021
Affimed NV (NASDAQ:AFMD) has announced
Via
Benzinga
Why Affimed Stock Is On Fire Today
November 22, 2021
The biotech's early-stage trial results are turning heads on Wall Street today.
Via
The Motley Fool
Why Affirmed Stock Was Up More Than 12% Wednesday
November 17, 2021
Positive trial results regarding the company's pipeline are buoying the stock's price.
Via
The Motley Fool
Mid-Afternoon Market Update: Dow Falls 200 Points; Rockwell Medical Shares Spike Higher
November 17, 2021
Toward the end of trading Wednesday, the Dow traded down 0.58% to 35,930.89 while the NASDAQ fell 0.27% to 15,930.79. The S&P also fell, dropping 0.23% to 4,690.24. The U.S....
Via
Benzinga
Topics
Stocks
Affimed NV (AFMD) Q3 2021 Earnings Call Transcript
November 10, 2021
AFMD earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
November 10, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus MorphoSys COO To Leave To Pursue Other Opportunities MorphoSys AG (NASDAQ:...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 21, 2021
October 21, 2021
Upgrades For Coterra Energy Inc (NYSE:CTRA), Piper...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 30, 2021
September 30, 2021
Upgrades For Cabot Oil & Gas Corp (NYSE:COG),...
Via
Benzinga
Affimed NV (NasdaqGM:AFMD) (AFMD) Q2 2021 Earnings Call Transcript
September 08, 2021
AFMD earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Earnings Scheduled For September 8, 2021
September 08, 2021
Companies Reporting Before The Bell • Nanobiotix (NASDAQ:NBTX) is likely to report earnings for its first quarter. • Waterdrop (NYSE:WDH) is expected to report...
Via
Benzinga
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
September 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc...
Via
Benzinga
The Week Ahead In Biotech (Sept. 5-11): Focus On Conferences and Clinical Readouts In Another Quiet Week
September 05, 2021
Biotech stocks extended their gains in the week ending Sept. 3, partly aided by the broader market strength. The news flow was fairly light ahead of the Labor Day holiday...
Via
Benzinga
Analyzing Affimed's Unusual Options Activity
July 13, 2021
Shares of Affimed (NASDAQ:AFMD) saw some unusual options activity on Tuesday. Following the unusual option alert, the stock price moved down to $6.77. Sentiment: BEARISH Option...
Via
Benzinga
The Daily Biotech Pulse: Spero Spikes On Pfizer Investment, FDA Nod For Jazz, Orchard Signs Licensing Deal, Acumen Pharma Debuts
July 01, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 30) Ambrx Biopharma Inc. (NYSE...
Via
Benzinga
Earnings Scheduled For July 1, 2021
July 01, 2021
Companies Reporting Before The Bell • Simply Good Foods (NASDAQ:SMPL) is projected to report quarterly earnings at $0.29 per share on revenue of $244.29 million....
Via
Benzinga
The Week Ahead In Biotech: Mediwound, Provention FDA Decisions, IPOs, Pending Clinical Readouts In Focus
June 27, 2021
Biotech stocks reversed course and closed the week ended June 25 higher, thanks to the positive broader market sentiment. Eli Lilly and Company (NYSE: LLY) stood out among big...
Via
Benzinga
Affimed's AFM13 In Combination With NK Cells Show Improved Tumor Recognition, Killing In Preclinical Studies
May 14, 2021
Affimed NV (NASDAQ: AFMD) has announced the publication of in vitro and in vivo research of its lead innate cell engager (ICE), AFM13 (CD16A/CD30), combined...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.